- Home
- JMSB vs RCKT Comparison
JMSB vs RCKT Comparison
Compare JMSB & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMSB
- RCKT
- Stock Information
- Founded
- JMSB 2005
- RCKT 1999
- Country
- JMSB United States
- RCKT United States
- Employees
- JMSB N/A
- RCKT N/A
- Industry
- JMSB Major Banks
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- JMSB Finance
- RCKT Health Care
- Exchange
- JMSB Nasdaq
- RCKT Nasdaq
- Market Cap
- JMSB 276.5M
- RCKT 328.6M
- IPO Year
- JMSB N/A
- RCKT N/A
- Fundamental
- Price
- JMSB $19.03
- RCKT $3.47
- Analyst Decision
- JMSB Buy
- RCKT Buy
- Analyst Count
- JMSB 2
- RCKT 13
- Target Price
- JMSB $22.50
- RCKT $12.88
- AVG Volume (30 Days)
- JMSB 16.2K
- RCKT 2.3M
- Earning Date
- JMSB 10-22-2025
- RCKT 11-06-2025
- Dividend Yield
- JMSB 1.58%
- RCKT N/A
- EPS Growth
- JMSB 688.28
- RCKT N/A
- EPS
- JMSB 1.32
- RCKT N/A
- Revenue
- JMSB $56,750,000.00
- RCKT N/A
- Revenue This Year
- JMSB $18.36
- RCKT N/A
- Revenue Next Year
- JMSB $12.36
- RCKT $108.43
- P/E Ratio
- JMSB $14.42
- RCKT N/A
- Revenue Growth
- JMSB 59.00
- RCKT N/A
- 52 Week Low
- JMSB $13.81
- RCKT $2.19
- 52 Week High
- JMSB $26.52
- RCKT $18.89
- Technical
- Relative Strength Index (RSI)
- JMSB 40.76
- RCKT 48.56
- Support Level
- JMSB $19.25
- RCKT $3.10
- Resistance Level
- JMSB $19.90
- RCKT $3.44
- Average True Range (ATR)
- JMSB 0.56
- RCKT 0.17
- MACD
- JMSB -0.18
- RCKT -0.01
- Stochastic Oscillator
- JMSB 0.00
- RCKT 36.17
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.